Background
Nahmias, Yaakov was born on April 2, 1974 in Tel Aviv, Israel.
Nahmias, Yaakov was born on April 2, 1974 in Tel Aviv, Israel.
Bachelor of Science, Technion, Haifa, Israel, 1999. Doctor of Philosophy, University Minnesota, Minneapolis, 2004. Postdoctoral, Harvard Medical School, Boston, Massachusetts, 2006.
Yaakov Nahmias received his Bachelor of Science in Chemical Engineering and Biology from the Technion – Israel Institute of Technology, graduating Magna Cum Laude. He completed his Doctor of Philosophy at the University of Minnesota with David Odde, and his postdoctoral training at Harvard Medical School with Martin Yarmush. In 2006, he became an independent investigator at Harvard Medical School, winning a National Institutes of Health Scientist Development Award (K01).
In 2012, Nahmias together with Chaim Lotan, established BioDesign Israel, a multi-disciplinary program in medical innovation taught at the Hebrew University of Jerusalem and its affiliated Hadassah Medical Center.
Nahmias is a liver biologist and a biomedical engineer who took part in the development of Lodamin, the first oral, broad-spectrum angiogenesis inhibitor and the first decellularization of an intact liver for transplantation. His own work showed that the Hepatitis C Virus (HCV) assembles on VLDL and that its production is blocked by the grapefruit flavonoid naringenin.
Nahmias" work is leading to a growing understanding of the role of diet and nutrition on liver metabolism, including the first demonstration that gut bacteria affect liver development after birth, and explaining the toxic affects of acetaminophen using liver-on-chip technology.
Nahmias is the founding director of the Alexander Grass Center for Bioengineering and an affiliated member of the National Institutes of Health-funded Biological Microelectromechanical Systems Resource Center at Massachusetts General Hospital. Nahmias edited a book titled Microdevices in Biology and Medicine, and is currently serving as a technology consultant for L’Oreal, and a member of the European Council panel for applied life sciences and biotechnology. In 2010, Nahmias became a Golda Meir fellow and a member of the European Research Council Starting Grant panel on applied life sciences and biotechnology (LS9).
Married.